Mandate

Vinge advises Capio in connection with acquisition of Backa Läkarhus

January 05, 2017

Capio Närsjukvård AB, a wholly owned subsidiary of Capio AB (publ) listed on Nasdaq Stockholm, has entered into an agreement for the acquisition of all shares in Backa Läkarhus AB which conducts operations through eleven district health centres and nine rehabilitation centres in the Västra Götaland Region and Region Halland.

The operations had a turnover of approximately MSEK 345 in 2016, and have 83 000 listed patients. Closing is subject to customary closing conditions from the relevant county councils and unconditional approval from the Swedish Competition Authority. The enterprise value amounts to MSEK 300.

Vinge’s team primarily consists of client responsible partner Anders Strid, Frida Bäckegren (project leader M&A), Lina André and Jonas Lindblad (employment), Gabriella Fossum (procurement), Mercedes Anderås (real estate), Camilla Andersson (corporate) as well as Pär Remnelid, among others (competition).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025